DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
TARIBAVIRIN
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
TARIBAVIRIN
×
Maximum Phase:
2
First Approval:
None
UNII:
R3B1994K2E
Molecule Type:
Small molecule
Molecular Formula:
C8H13N5O4
Molecular Weight:
243.22
AlogP:
-2.83
PSA:
150.5
HBD:
5.0
HBA:
#RotB:
3.0
Source:
PUMOSETRAG
2
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux; Irritable Bowel Syndrome
Unknown
PUMOSETRAG
×
Maximum Phase:
2
First Approval:
None
UNII:
1G26B32139
Molecule Type:
Small molecule
Molecular Formula:
C15H17N3O2S
Molecular Weight:
303.39
AlogP:
1.41
PSA:
65.2
HBD:
2.0
HBA:
#RotB:
2.0
Source:
LIAFENSINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder
Monoamine transporter inhibitor
LIAFENSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
R34ID086Z6
Molecule Type:
Small molecule
Molecular Formula:
C24H22N4
Molecular Weight:
366.47
AlogP:
4.46
PSA:
55.04
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PERZINFOTEL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Glutamate [NMDA] receptor antagonist
PERZINFOTEL
×
Maximum Phase:
2
First Approval:
None
UNII:
FX5AUU7Z8T
Molecule Type:
Small molecule
Molecular Formula:
C9H13N2O5P
Molecular Weight:
260.19
AlogP:
-0.92
PSA:
106.94
HBD:
3.0
HBA:
#RotB:
3.0
Source:
ANX-005
2
Unknown
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis; Anemia, Hemolytic, Autoimmune; Guillain-Barre Syndrome; Huntington Disease
Unknown
ANX-005
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEANUT
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PEANUT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IBUTAMOREN MESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Fibromyalgia
Ghrelin receptor agonist
IBUTAMOREN MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
R90JB6QJ2B
Molecule Type:
Small molecule
Molecular Formula:
C28H40N4O8S2
Molecular Weight:
624.78
AlogP:
1.77
PSA:
122.04
HBD:
2.0
HBA:
#RotB:
8.0
Source:
N-METHYL-D-ASPARTIC ACID (NMDA)
2
Small molecule
Investigational
Unknown
Unknown
Brain Injuries; Borderline Personality Disorder; Depressive Disorder, Major
Unknown
N-METHYL-D-ASPARTIC ACID (NMDA)
×
Maximum Phase:
2
First Approval:
None
UNII:
1903B9Q6PI
Molecule Type:
Small molecule
Molecular Formula:
C5H9NO4
Molecular Weight:
147.13
AlogP:
-0.87
PSA:
86.63
HBD:
3.0
HBA:
#RotB:
4.0
Source:
SI-613
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SI-613
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOTANOC
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DOTANOC
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
WHARTON JELLY DERIVED MESENCHYMAL STEM CELL
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
WHARTON JELLY DERIVED MESENCHYMAL STEM CELL
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALSACLIDINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Muscarinic acetylcholine receptor M1 agonist
TALSACLIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
1O8VSL798T
Molecule Type:
Small molecule
Molecular Formula:
C10H15NO
Molecular Weight:
165.24
AlogP:
0.73
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
2.0
Source:
CHLOROGENIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Lung Neoplasms; Neoplasms; Glioblastoma; Glucose Intolerance
Unknown
CHLOROGENIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
318ADP12RI
Molecule Type:
Small molecule
Molecular Formula:
C16H18O9
Molecular Weight:
354.31
AlogP:
-0.65
PSA:
164.75
HBD:
6.0
HBA:
#RotB:
4.0
Source:
URTOXAZUMAB
2
Antibody
Investigational
Unknown
Unknown
Unknown
Shiga toxin subunit B inhibitor
URTOXAZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
232D35B3NT
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELESCLOMOL SODIUM
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ELESCLOMOL SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETIOPURPURIN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ETIOPURPURIN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C37H44N4O2
Molecular Weight:
576.79
AlogP:
8.81
PSA:
83.66
HBD:
2.0
HBA:
#RotB:
6.0
Source:
AME-133V
2
Antibody
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Integrin beta-2 inhibitor
AME-133V
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UPRIFOSBUVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Unknown
UPRIFOSBUVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
JW31KPS26S
Molecule Type:
Small molecule
Molecular Formula:
C22H29ClN3O9P
Molecular Weight:
545.91
AlogP:
1.93
PSA:
158.18
HBD:
3.0
HBA:
#RotB:
10.0
Source:
AZD-4877
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms
Kinesin-like protein 1 inhibitor
AZD-4877
×
Maximum Phase:
2
First Approval:
None
UNII:
19ORU63E06
Molecule Type:
Small molecule
Molecular Formula:
C28H33N5O2S
Molecular Weight:
503.67
AlogP:
4.71
PSA:
94.11
HBD:
1.0
HBA:
#RotB:
9.0
Source:
PHENCYNONATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PHENCYNONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
H84F112WBJ
Molecule Type:
Small molecule
Molecular Formula:
C22H31NO3
Molecular Weight:
357.49
AlogP:
3.34
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BEMNIFOSBUVIR HEMISULFATE
2
Unknown
Investigational
Unknown
Unknown
Hepatitis C, Chronic; Severe Acute Respiratory Syndrome
Unknown
BEMNIFOSBUVIR HEMISULFATE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HEXASODIUM PHYTATE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HEXASODIUM PHYTATE
×
Maximum Phase:
2
First Approval:
None
UNII:
ZBX50UG81V
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-232802
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-232802
×
Maximum Phase:
2
First Approval:
None
UNII:
AG92SGO434
Molecule Type:
Small molecule
Molecular Formula:
C24H28O3
Molecular Weight:
364.49
AlogP:
6.13
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TNP-470
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TNP-470
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CP1-1189
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
CP1-1189
×
Maximum Phase:
2
First Approval:
None
UNII:
9JX1L8VH4Z
Molecule Type:
Small molecule
Molecular Formula:
C13H18N2O2
Molecular Weight:
234.3
AlogP:
2.17
PSA:
58.2
HBD:
2.0
HBA:
#RotB:
2.0
Source:
BICYCLOL
2
Small molecule
Investigational
Unknown
Unknown
Wounds and Injuries
Unknown
BICYCLOL
×
Maximum Phase:
2
First Approval:
None
UNII:
9734122TH2
Molecule Type:
Small molecule
Molecular Formula:
C19H18O9
Molecular Weight:
390.34
AlogP:
2.11
PSA:
101.91
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FP-1039
2
Unknown
Investigational
Unknown
Unknown
Neoplasms; Endometrial Neoplasms
Unknown
FP-1039
×
Maximum Phase:
2
First Approval:
None
UNII:
CTG26PRE5S
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISPRONICLINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Attention Deficit Disorder with Hyperactivity; Memory Disorders; Schizophrenia
Neuronal acetylcholine receptor; alpha4/beta2 partial agonist
ISPRONICLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
3E05NBH9V5
Molecule Type:
Small molecule
Molecular Formula:
C14H22N2O
Molecular Weight:
234.34
AlogP:
2.88
PSA:
34.15
HBD:
1.0
HBA:
#RotB:
6.0
Source:
OCTANOL
2
Small molecule
Investigational
Unknown
Unknown
Essential Tremor
Unknown
OCTANOL
×
Maximum Phase:
2
First Approval:
None
UNII:
NV1779205D
Molecule Type:
Small molecule
Molecular Formula:
C8H18O
Molecular Weight:
130.23
AlogP:
2.34
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ORN-0829 HYDRATE
2
Unknown
Investigational
Unknown
Unknown
Sleep Apnea, Obstructive; Sleep Initiation and Maintenance Disorders
Orexin receptor antagonist
ORN-0829 HYDRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMG-714
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
AMG-714
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IROSUSTAT
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Endometrial Neoplasms
Steryl-sulfatase inhibitor
IROSUSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
366037O6O7
Molecule Type:
Small molecule
Molecular Formula:
C14H15NO5S
Molecular Weight:
309.34
AlogP:
1.64
PSA:
99.6
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PF-03654764
2
Small molecule
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal
Histamine H3 receptor antagonist
PF-03654764
×
Maximum Phase:
2
First Approval:
None
UNII:
FPI2G03BJ1
Molecule Type:
Small molecule
Molecular Formula:
C20H28F2N2O
Molecular Weight:
350.45
AlogP:
3.77
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
6.0
Source:
VK5211
2
Small molecule
Investigational
Unknown
Unknown
Hip Fractures
Androgen Receptor modulator
VK5211
×
Maximum Phase:
2
First Approval:
None
UNII:
1EJT54415A
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
URIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Ischemic Stroke
Unknown
URIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
268B43MJ25
Molecule Type:
Small molecule
Molecular Formula:
C5H4N4O3
Molecular Weight:
168.11
AlogP:
-0.53
PSA:
115.15
HBD:
4.0
HBA:
#RotB:
0.0
Source:
1
2
…
158
159
160
161
162
163
164
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA